RG 7600 companion diagnostic - Genentech

Drug Profile

RG 7600 companion diagnostic - Genentech

Alternative Names: 89Zr-MMOT0530A; DMOT 4039A companion diagnostic - Genentech; MMOT 0530A Zr 89; Zirconium-89 MMOT 0530A

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Genentech
  • Developer Genentech; University Medical Center Groningen; VU University Medical Center
  • Class Immunoconjugates; Monoclonal antibodies; Monoclonal antibody diagnostics; Radiopharmaceutical diagnostics; Radiopharmaceuticals
  • Mechanism of Action Ionising radiation emitters; Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Ovarian cancer; Pancreatic cancer

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Ovarian-cancer(Diagnosis) in Netherlands (Parenteral)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Pancreatic-cancer(Diagnosis) in Netherlands (Parenteral)
  • 01 May 2014 The University Medical Center Gronigen completes a phase I study for Pancreatic and Ovarian cancer (diagnosis) in the Netherlands (NCT01832116)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top